Results 21 to 30 of about 1,464 (122)

Structure of the uncleaved ectodomain of the paramyxovirus (hPIV3) fusion protein [PDF]

open access: yesProceedings of the National Academy of Sciences, 2005
Class I viral fusion proteins share common mechanistic and structural features but little sequence similarity. Structural insights into the protein conformational changes associated with membrane fusion are based largely on studies of the influenza virus hemagglutinin in pre- and postfusion conformations.
Hsien-Sheng, Yin   +4 more
openaire   +2 more sources

Structure-Guided Improvement of a Dual HPIV3/RSV Fusion Inhibitor [PDF]

open access: yesJournal of the American Chemical Society, 2019
Human parainfluenza virus 3 (HPIV3) and respiratory syncytial virus (RSV) are leading causes of lower respiratory tract infections. There are currently no vaccines or antiviral therapeutics to treat HPIV3 or RSV infections. We recently reported a peptide (VIQKI), derived from the C-terminal heptad repeat (HRC) domain of the HPIV3 fusion (F ...
Victor K. Outlaw   +5 more
openaire   +2 more sources

Genetic Characteristics of Human Parainfluenza Virus Types 1–4 From Patients With Clinical Respiratory Tract Infection in China

open access: yesFrontiers in Microbiology, 2021
Human parainfluenza viruses (HPIV1–4) cause acute respiratory tract infections, thereby impacting human health worldwide. However, there are no current effective antivirals or licensed vaccines for infection prevention. Moreover, sequence information for
Nan Shao   +11 more
doaj   +1 more source

Protective Antibodies Against Human Parainfluenza Virus Type 3 (HPIV3) Infection [PDF]

open access: yes, 2020
ABSTRACT Human parainfluenza virus type III (HPIV3) is a common respiratory pathogen that afflicts children and can be fatal in vulnerable populations, including the immunocompromised. Unfortunately, an effective vaccine or therapeutic is not currently available, resulting in tens of thousands of hospitalizations per ...
Jim Boonyaratanakornkit   +10 more
openaire   +1 more source

Differential regulation of type I interferon and epidermal growth factor pathways by a human Respirovirus virulence factor. [PDF]

open access: yesPLoS Pathogens, 2009
A number of paramyxoviruses are responsible for acute respiratory infections in children, elderly and immuno-compromised individuals, resulting in airway inflammation and exacerbation of chronic diseases like asthma.
Grégory Caignard   +10 more
doaj   +1 more source

The p Value of HPIV3-Mediated Autophagy Inhibition [PDF]

open access: yesCell Host & Microbe, 2014
Autophagy, a vesicular pathway involving the lysosomal degradation of cytosolic contents, is frequently hijacked by intracellular pathogens to optimize their infectivity. In this issue of Cell Host & Microbe, Ding et al. (2014) show that human parainfluenza virus exploits autophagy by targeting SNAREs and preventing the SNAP29-Stx17 interaction, an ...
openaire   +4 more sources

Virion-Associated Cholesterol Regulates the Infection of Human Parainfluenza Virus Type 3

open access: yesViruses, 2019
The matrix (M) proteins of paramyxoviruses bind to the nucleocapsids and cytoplasmic tails of glycoproteins, thus mediating the assembly and budding of virions.
Qiaopeng Tang   +3 more
doaj   +1 more source

Human parainfluenza virus type 1 regulates cholesterol biosynthesis and establishes quiescent infection in human airway cells.

open access: yesPLoS Pathogens, 2021
Human parainfluenza virus type 1 (hPIV1) and 3 (hPIV3) cause seasonal epidemics, but little is known about their interaction with human airway cells. In this study, we determined cytopathology, replication, and progeny virion release from human airway ...
Yuki Kurebayashi   +6 more
doaj   +1 more source

UK circulating strains of human parainfluenza 3: an amplicon based next generation sequencing method and phylogenetic analysis [version 2; referees: 2 approved]

open access: yesWellcome Open Research, 2018
Background: Human parainfluenza viruses type 3 (HPIV3) are a prominent cause of respiratory infection with a significant impact in both pediatric and transplant patient cohorts.  Currently there is a paucity of whole genome sequence data that would allow
Anna Smielewska   +5 more
doaj   +1 more source

Human parainfluenza virus type 3 expressing the respiratory syncytial virus pre-fusion F protein modified for virion packaging yields protective intranasal vaccine candidates.

open access: yesPLoS ONE, 2020
Human respiratory syncytial virus (RSV) and parainfluenza virus type 3 (HPIV3) are among the most common viral causes of childhood bronchiolitis and pneumonia worldwide, and lack effective antiviral drugs or vaccines.
Xueqiao Liu   +8 more
doaj   +1 more source

Home - About - Disclaimer - Privacy